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Objectives : Whilst hypertension exerts a negative effect
on several organs there have been few studies regarding
its effect on pulmonary function. The objective of this study
was to examine the relationship between hypertension and
pulmonary function in rural Korean adults
Methods : In 2006, 2534 people were recruited, aged 40
to 70, in Kangwha County. We selected 1454 (male: 624,
female: 830) participants whose pulmonary function results
were repeatable. Blood pressure (BP) was measured twice
and the average calculated. Participants were divided into
two groups (hypertensive group and non-hypertensive
group) in accordance with The Seventh Report of the Joint
National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. Pulmonary function
was measured by dry roll ing seal spirometry. Forced
expiratory volume in the one second and forced vital
capacity were converted into percent-predicted values
based on average pulmonary function amongst Koreans.
Results : The number of hypertensive participants in the
present study was 460 (male: 205, female: 255) and the
number of non-hypertensive participants was 994 (male:
419, female: 575). Our findings have shown that the mean
values for expiratory volume in the one second and forced
vital capacity were significantly lower for hypertensive
people than for non-hypertensive people, among women
(P=0.002 for forced expiratory volume in the one second,
P<0.001 for forced vital capacity volume). Odds ratio
analysis revealed that hypertensive participants were more
l ike ly to have lower pulmonary funct ion than non-
hypertensive part icipants, again signif icantly among
women.
Conclusions : The pulmonary function of hypertensive
women was s igni f icant ly  lower than that  of  non-
hypertensive women aged 40-70.
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forced expiratory volume in the one second,
FEV1 predictive value(%); Percent-predicted
value for forced volume capacity; FVC
predictive value(%)] [17]. 
. 
(cutoff values) FEV1
predictive value(%) 83%, FEV1
predictive value(%) 88%, FVC
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Table 1. Characteristics of study participants (Total)

























Family Hx of HTN (N)
BMI: body mass index, COPD: chronic obstructive pulmonary disease, DBP: diastolic blood pressure, FEV1: forced
expiratory volume in the one second, FVC: forced volume capacity, hs-CRP: serum high sensitivity C-reactive protein, 
HTN: hypertension, Hx: history, SBP: systolic blood pressure 


























































Table 2. Characteristics of study participants (Included)
























Family Hx of HTN (N)
BMI: body mass index, COPD: chronic obstructive pulmonary disease, DBP: diastolic blood pressure, FEV1: forced
expiratory volume in the one second, FVC: forced volume capacity, hs-CRP: serum high sensitivity C-reactive protein, 
HTN: hypertension, Hx: history, SBP: systolic blood pressure 



























































































tive value(%), FVC predictive value(%) 
, 
FEV1 predictive value(%), FVC predic-
tive value(%) 
1.539 (95% CI=1.132-
2.093), 1.964 (95% CI=1.446-2.666) ,
. 
FEV1 predictive value(%), FVC
predictive value(%) , 
FEV1 predic-
tive value(%), FVC predictive value(%) 




tive value(%), FVC predictive value(%) 
, 
FEV1 predictive value(%), FVC
predictive value(%) 
1.605 (95% CI=1.153
-2.235), 1.651 (95% CI=1.189-2.292) ,
. 
FEV1 predictive value(%), FVC
predictive value(%) , 
FEV1 predic-
tive value(%), FVC predictive value(%) 
1.215 (95% CI=0.837-1.762), 1.001 (95%
CI=0.692-1.448) , 
(Table 4).
FEV1 predictive value(%), FVC predictive
value(%) , 
FEV1 predictive value(%),
FVC predictive value(%) 
0.785 (95%
CI=0.408-1.511), 0.939 (95% CI=0.480-1.838)
, . 
FEV1 predictive value(%), FVC predictive
value(%) , 
Figure 1. Pulmonary functions test’s values .
FEV1p(%): percent-predicted value for forced expiratory volume in the one second,
FVCp(%): percent-predicted value for forced volume capacity, HTN: hypertension
Figure 2. Pulmonary functions test’s values .
FEV1p(%): percent-predicted value for forced expiratory volume in the one second,
FVCp(%): percent-predicted value for forced volume capacity, HTN: hypertension
Figure 3. Pulmonary functions test’s values .
FEV1p(%): percent-predicted value for forced expiratory volume in the one second,
FVCp(%): percent-predicted value for forced volume capacity, HTN: hypertension
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FEV1 predictive value(%),
FVC predictive value(%) 
1.555 (95%
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value(%) FVC predictive value(%) 
, 
FEV1 predictive value(%)
FVC predictive value(%) ,





Table 4. Adjusted odds ratio of lowest FEV1 predict(%) and lowest FVC predict(%) according to
hypertension (male, female)








Adjusted for age, body mass index, physical activity, smoking
CI: confidence interval, FEV1 predect(%): percent-predicted value for forced expiratory volume in the one second, 



















Table 3. Crude odds ratio of lowest FEV1 predict (%) and lowest FVC predict(%) according to
hypertension


























Table 5. Adjusted odds ratio of lowest FEV1 predict(%) and lowest FVC predict(%) according to
hypertension (male smoker, male non-smoker)








Adjusted for age, body mass index, physical activity
CI: confidence interval, FEV1 predect(%): percent-predicted value for forced expiratory volume in the one second, 
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